Lasa Supergenerics Share Price
6.84+0.02 (+0.29%)
-21.74% past 1 Year
Lasa Supergenerics Limited was incorporated in 2016 having its registered office in Ratnagiri, Maharashtra. The company is primarily engaged in the business of manufacturing API bulk drugs products.
Corporate filings & documents
Announcements
Regulations 2015 we would like to inform you that the Board of Directors in their meeting held today i.e . August 26 2026 which was commenced at 11.00 a.m. and concluded at 1.00 p.m inter- alia have considered and approved the following: 1. Appointment of Mr. Janardan Kamlu Savala as an Additional Director in Capacity of (Executive Director) and Occupier of All units of the Company.Further the aforesaid appointment shall be subject to approval of members at the ensuing General Meeting/ Postal Ballot of the Company
1 week agoRegulations 2015 we would like to inform you that the Board of Directors in their meeting held today i.e . August 26 2026 which was commenced at 11.00 a.m. and concluded at 1.00 p.m inter- alia have considered and approved the following: 1. Appointment of Mr. Janardan Kamlu Savala as an Additional Director in Capacity of (Executive Director) and Occupier of All units of the Company.Further the aforesaid appointment shall be subject to approval of members at the ensuing General Meeting/ Postal Ballot of the Company
1 week agoResignation of Mr. Ganesh Potdar executive director as on 25-08-2026
1 week agoResignation of Mr. Ganesh Potdar executive director as on 25-08-2026
1 week agoIntegrated filing for Quarter ended June 30 2026
2 weeks agoIntegrated filing for Quarter ended June 30 2026
2 weeks agoPursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations 2015 we would like to inform you that the Board of Directors in their meeting held today which was commenced at 2.00 P.M. and concluded at 06.15 P.M. inter- alia have considered and approved the following: 1. The Unaudited Financial Results of the Company for the quarter ended June 30 2026.2. Limited Review Report from Statutory Auditor for the quarter ended on June 30 2026.
2 weeks agoPursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations 2015 we would like to inform you that the Board of Directors in their meeting held today which was commenced at 2.00 P.M. and concluded at 06.15 P.M. inter- alia have considered and approved the following: 1. The Unaudited Financial Results of the Company for the quarter ended June 30 2026.2. Limited Review Report from Statutory Auditor for the quarter ended on June 30 2026.
2 weeks agoLasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Friday August 14 2026 inter alia;1. To consider approve and take on records Unaudited financial results of the Company for the quarter ended June 30 2026.2. To discuss any other matter with the permission of the Chairperson.
1 month agoLasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Friday August 14 2026 inter alia;1. To consider approve and take on records Unaudited financial results of the Company for the quarter ended June 30 2026.2. To discuss any other matter with the permission of the Chairperson.
1 month agoClosure of trading window for the quarter ended June 30 2026
2 months agoClosure of trading window for the quarter ended June 30 2026
2 months agoAnnual Secretarial Compliance Report as on March 31st 2026
3 months agoAnnual Secretarial Compliance Report as on March 31st 2026
3 months agoIntegrated filings as on 31st march 2026
3 months agoIntegrated filings as on 31st march 2026
3 months agoRelated party transaction as on 31 st march 2026
3 months agoRelated party transaction as on 31 st march 2026
3 months agoRevised outcome of board meeting for quarter ended 31 march 2026
3 months agoRevised outcome of board meeting for quarter ended 31 march 2026
3 months agoOutcome of board meeting for the quarter ended 31st march 2026
3 months agoOutcome of board meeting for the quarter ended 31st march 2026
3 months agoLasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Friday May 29 2026 inter alia;1. To consider approve and take on records Audited financial results of the Company for the quarter and the year ended March 31 2026. 2. To discuss any other matter with the permission of the Chairperson.
3 months agoCertificate Reg 74 (5) of SEBI (DP) Regulations 2018 as on 31st March 2026
3 months agoCertificate Reg 74 (5) of SEBI (DP) Regulations 2018 as on 31st March 2026
3 months agoDeclaration with respect to non- applicability of Large Entities
4 months agoDeclaration with respect to non- applicability of Large Entities
4 months agoClosure of trading window for the quarter and year ended March 31 2026
5 months agoClosure of trading window for the quarter and year ended March 31 2026
5 months agoIntegrated filing for quarter ended December 31 2025
6 months agoIntegrated filing for quarter ended December 31 2025
6 months agoResults for quarter ended 31st December 2025
6 months agoResults for quarter ended 31st December 2025
6 months agoPursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations 2015 we would like to inform you that the Board of Directors in their meeting held today which was commenced at 2.00 P.M. and concluded at 03.15 P.M. inter- alia have considered and approved the following: 1. The Unaudited Financial Results of the Company for the quarter ended December 31 2025.2. Limited Review Report from Statutory Auditor for the quarter ended on December 31 2025.
6 months agoPursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations 2015 we would like to inform you that the Board of Directors in their meeting held today which was commenced at 2.00 P.M. and concluded at 03.15 P.M. inter- alia have considered and approved the following: 1. The Unaudited Financial Results of the Company for the quarter ended December 31 2025.2. Limited Review Report from Statutory Auditor for the quarter ended on December 31 2025.
6 months agoLasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Friday February 13 2026 inter alia;1. To consider approve and take on records Unaudited financial results of the Company for the quarter ended December 31 2025.2. To discuss any other matter with the permission of the Chairperson.
7 months agoCertificate under Reg 74 (5) of SEBI (DP) Regulations 2018
7 months agoPursuant to Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations 2015 we would like to inform you that the Board of Directors in their meeting held today i.e . January 02 2026 which was commenced at 2.00 p.m. and concluded at 4.00 p.m inter- alia have considered and approved the following: 1. Appointment of Mr. Ganesh Suresh Potdar as an Additional Director in Capacity of (Executive Director) and Occupier of All units of the Company.Further the aforesaid appointment shall be subject to approval of members at the ensuing General Meeting/ Postal Ballot of the Company.
8 months agoClosure of trading window for the quarter ended December 31 2025
8 months agoWe wish to inform you that Mrs. Mitti Jain is hereby appoitned as Company secretary and Compliance Officer of the Company
8 months agoWe would llike to inform you that Mr. Prathmesh Chalke tendered his resignation as Whole-time Director of the Company .
8 months agoRelated party transaction as on 30.09.2025
9 months agoIntegrated filing September 30 2025
9 months agoResults as on 30.09.2025
9 months agoPursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations 2015 we would like to inform you that the Board of Directors in their meeting held today which was commenced at 2.30 P.M. and concluded at 05.00 P.M. inter- alia have considered and approved the following: 1. The Unaudited Financial Results of the Company for the quarter and half year ended September 30 2025.2. Limited Review Report from Statutory Auditor for the quarter and half year ended on September 30 2025.
9 months agoThe Board Meeting to be held on 14/11/2025 has been revised to 14/11/2025 The Board Meeting to be held on 14/11/2025 has been revised to 14/11/2025
9 months agoLasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation 2015 notice is hereby given that Meeting of the Board of Directors of the Company is scheduled to be held on Friday August 14 2025 inter alia;1. To consider approve and take on records Unaudited financial results of the Company for the quarter and half year ended September 30 2025.2. To discuss any other matter with the permission of the Chairperson.In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 and Companys Code of Conduct the Trading Window shall continue to remain closed till 48 hours after the declaration of the unaudited financial results of the Company for the quarter and half year ended September 30 2025.
10 months agoPlease find enclosed herewith certificate of 74 (5) of SEBI (DP) Regulations 2018 for the quarter ended September 30 2025 received from RTA Bigshare Services Private Limited
10 months agoIn terms of the subject referred the details regarding consolidated voting results of the business transacted at the 10th Annual General Meeting (AGM) of the company held on Tuesday 30th September 2025
11 months agoPursuant to Reg 30 SEBI (LODR) 2015 as amended we hereby submitting the summary of the proceedings of the 10 th AGM of the Company held on 30th September 2025 at 11.00 AM and Concluded at 11.20 through video conferencing.
11 months agoAnnual reports
Concalls & investor presentations
Corporate Actions
Date
Type
Details
2021-09-15
Dividend
0.25
Company details
Registered office
C-4, C-4/1, M I D C Lote Parshuram Industrial Area Tal- Khed Ratnagiri Dist Maharashtra PIN: 415722 Tel No: 02145 232101 / 232202 Fax No: NULL Email: [email protected] Internet: www.lasalabs.com
Registrars
PIN: Tel No: Fax No: Email:
Management
Omkar Pravin Herlekar, Chairman & Managing Director
Omkar Pravin Herlekar, Chairman & Managing Director
Ketan Bhau Songal, Non Executive Independent Director
Pravin Gadalya Lachake, Non Executive Independent Director
Yogesh Hari Ughada, Non Executive Independent Director
Rekha Hmant Wakh, Non Executive Independent Director
Mitti Jain, Company Secretary & Compliance Officer
Details
BSE 540702
NSE LASA
ISIN INE670X01014